Literature DB >> 12067820

Diagnostic value of C-reactive protein in exudative pleural effusions.

E Garcia-Pachon1, I Llorca.   

Abstract

BACKGROUND: Tests able to help in the diagnostic work-up of pleural exudates are needed. C-reactive protein (CRP) may be useful for distinguishing between benign and malignant exudates.
METHODS: A total of 123 consecutive patients diagnosed as having exudative pleural effusion (60 associated with malignancy and 63 benign effusions) were included in the study. Sensitivity, specificity, positive and negative predictive values (PV+, PV-), and positive and negative likelihood ratios (LR+, LR-) were established at different cut-off points.
RESULTS: Pleural fluid CRP level was 23+/-12 mg/l (mean+/-S.D.) in pleural exudates associated with malignancy and 50+/-33 mg/l in benign effusions (P<0.001). With a cut-off point below 20 mg/l for malignancy, sensitivity of CRP was 0.50, specificity 0.89, PV+ 0.81, PV- 0.65, LR+ 4.50, and LR- 0.65. With a cut-off point above 45 mg/l for benign diseases, sensitivity was 0.44, specificity 0.95, PV+ 0.90, PV- 0.62, LR+ 8.89, and LR- 0.58.
CONCLUSIONS: The pleural CRP level provides useful information for the study of pleural exudates. A level below 20 mg/l suggests a malignant origin and a level above 45 mg/l virtually rules out this possibility. Additional advantages of measuring CRP level are that it is an inexpensive test and is easy to perform.

Entities:  

Year:  2002        PMID: 12067820     DOI: 10.1016/s0953-6205(02)00036-5

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  6 in total

1.  Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.

Authors:  S C Chen; W Chen; W H Hsu; Y H Yu; C M Shih
Journal:  Lung       Date:  2006 May-Jun       Impact factor: 2.584

2.  Diagnostic value of procalcitonin in pleural effusions.

Authors:  C-Y Wang; Y-C Hsiao; J-S Jerng; C-C Ho; C-C Lai; C-J Yu; P-R Hsueh; P-C Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-13       Impact factor: 3.267

3.  Diagnostic accuracy of tumour markers in serous effusions: a validation study.

Authors:  Jaume Trapé; Rafael Molina; Francesc Sant; Jesús Montesinos; Anna Arnau; Josefina Franquesa; Rosana Blavia; Esperanza Martín; Emili Marquilles; Damià Perich; Concepción Pérez; Josep Maria Roca; Montserrat Doménech; Joan López; Josep Miquel Badal
Journal:  Tumour Biol       Date:  2012-06-08

4.  Endostatin levels in exudative pleural effusions.

Authors:  M Sumi; K Kagohashi; H Satoh; H Ishikawa; Y Funayama; K Sekizawa
Journal:  Lung       Date:  2003 Nov-Dec       Impact factor: 2.584

5.  The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates.

Authors:  Alessandra M Okino; Cristiani Bürger; Jefferson R Cardoso; Edson L Lavado; Paulo A Lotufo; Ana Campa
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

6.  Evaluation of two strategies for the interpretation of tumour markers in pleural effusions.

Authors:  Jaume Trapé; Francesc Sant; Josefina Franquesa; Jesús Montesinos; Anna Arnau; Maria Sala; Oscar Bernadich; Esperanza Martín; Damià Perich; Concha Pérez; Joan Lopez; Sandra Ros; Enrique Esteve; Rafael Pérez; Jordi Aligué; Gabriel Gurt; Silvia Catot; Montserrat Domenech; Joan Bosch; Josep Miquel Badal; Mariona Bonet; Rafael Molina; Josep Ordeig
Journal:  Respir Res       Date:  2017-05-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.